COMMUNIQUÉS West-GlobeNewswire

Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2018

04/04/2019 - 22:30

COPENHAGEN, Denmark, April 04, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated financial results [...]

Zafgen, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

04/04/2019 - 22:30

BOSTON, April 04, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN) (the “Company”) a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies [...]

BeyondSpring to Present at the 18th Annual Needham Healthcare Conference

04/04/2019 - 22:30

NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, announced today that management will provide a [...]

Axovant Announces Plan to Effect Reverse Share Split

04/04/2019 - 22:10

- Closing of $40 million financing with participation from leading shareholders - - 1-for-8 reverse share split expected in May 2019 - BASEL, Switzerland, April 04, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. ( [...]

Vital Therapies, Inc. Announces Stockholder Approval of Business Combination with Immunic AG

04/04/2019 - 22:07

SAN DIEGO, April 04, 2019 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL) announced that its stockholders voted to approve the proposals required to complete the business combination with Immunic AG at a special [...]

Homology Medicines Presents Preclinical Data from PKU Gene Therapy Program Demonstrating Restored Metabolic Pathway and Increased Neurotransmitter Production

04/04/2019 - 22:05

Company Announced IND Clearance Today for Phase 1/2 Clinical Trial BEDFORD, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today preclinical [...]

Fluidigm Announces Conference Call and Webcast of First Quarter 2019 Financial Results

04/04/2019 - 22:05

SOUTH SAN FRANCISCO, Calif., April 04, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, [...]

Novartis updates on the migraine collaboration with Amgen

04/04/2019 - 22:01

Basel, April 4, 2019 - Novartis announced today that there is a legal dispute with Amgen regarding the collaboration agreements in the field of migraine. On April 2, 2019, Amgen issued a notice of termination of its [...]

IBRI issues its digital and print 2018 Annual Report, “Discovery With Purpose” Diabetes, biopharmaceutical research and health data analytics research expanded

04/04/2019 - 21:35

INDIANAPOLIS, April 04, 2019 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced the release of its print and digital 2018 Annual Report. The report theme is “Discovery With Purpose,” [...]

Generex Addresses Shareholder Concern Over 8-K and Quarterly Filing

04/04/2019 - 21:35

MIRAMAR, FL, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex would like to clarify the discussions surrounding the filed 10-Q ending the period of January 31, 2019, or the second quarter, filed on March [...]

Aleafia Health Launches Cannabis Education Platform FoliEdge Academy

04/04/2019 - 21:15

FoliEdge Academy Built with D2L, a World Leading Online Learning Company Insurance Technology Executive Rob Tyrie Named Head of FoliEdge Academy Interactive, Cloud-based Courses for Employers, Unions, Universities, [...]

IBT publishes annual report for 2018

04/04/2019 - 20:00

Today, Infant Bacterial Therapeutics AB (publ) publishes the Annual Report for the financial year 2018. The report is available on IBT’s website ibtherapeutics.com under the section “Investors & Media – Financial [...]

B. Braun Will Showcase Clorotekal® (chloroprocaine hydrochloride) at ASRA 2019

04/04/2019 - 19:36

BETHLEHEM, Pa., April 04, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. will present its first FDA-approved local anesthetic for spinal anesthesia -- Clorotekal ® (chloroprocaine hydrochloride) -- at the American [...]

Santhera Raises up to CHF 22.1 Million by Placement of Shares and Credit Line

04/04/2019 - 19:34

Pratteln, Switzerland, April 4, 2019 - Santhera Pharmaceuticals (SIX: SANN) announces that it has placed all of the remaining 500,000 registered shares from its existing authorized share capital in a private placement, [...]

SuperSonic Imagine will present its Aixplorer® MACH 30 ultrasound system at the American Institute of Ultrasound in Medicine (AIUM) annual convention from 6 to 10 April in Orlando, Florida, United States

04/04/2019 - 19:15

AIX-EN-PROVENCE, France, April 04, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814,), a company specialising in ultrasound medical imaging (diagnostic ultrasound), will introduce Aixplorer MACH [...]

Segra Receives “Confirmation of Readiness” from Health Canada for Plant Tissue Culture Production Facility

04/04/2019 - 19:05

VANCOUVER, British Columbia, April 04, 2019 (GLOBE NEWSWIRE) -- Segra International Corp. (“ Segra ” or the “ Company ”), a cannabis agriculture technology company, is pleased to announce that its application for [...]

Minutes of Ordinary General Meeting

04/04/2019 - 18:54

REFERAT AF ORDINÆR GENERALFORSAMLING MINUTES OF ORDINARY GENERAL MEETING PROTOKOLL FRÅN ÅRSSTÄMMA Der blev afholdt ordinær generalforsamling i Oncology Venture A/S (“ Selskabet “) 4. april 2019, kl. 16.00 i Søhuset, [...]

Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval

04/04/2019 - 18:31

NANOBIOTIX ANNOUNCES FIRST EVER RADIOENHANCER TO RECEIVE EUROPEAN MARKET APPROVAL Hensify®(NBTXR3) received European market approval (CE mark) enabling commercialization in 27 European Union countries for the treatment [...]

NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCHÉ EUROPEEN D’UN RADIOENHANCER

04/04/2019 - 18:31

NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCH É EUROPEEN D’UN RADIOENHANCER Hensify®(NBTXR3) a reçu une autorisation de mise sur le marché (Marquage CE) en Europe permettant sa commercialisation [...]